(Q54276180)

English

Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Ya-Bo Gao

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Zuo-Lin Xiang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Le-Yuan Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Zhi-Feng Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Jia Fan

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Hai-Ying Zeng

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Zhao-Chong Zeng

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

publication date

10 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

139

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

669-679

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

https://scigraph.springernature.com/pub.10.1007/s00432-012-1370-4

0 references

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Suppression of tumor growth through disruption of hypoxia-inducible transcription

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

CCN family 2/connective tissue growth factor (CCN2/CTGF) regulates the expression of Vegf through Hif-1alpha expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Genomics and signaling pathways in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Targeting hypoxia in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

A clinicopathological model to predict bone metastasis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1370-4

21 January 2018

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23307318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/23307318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23307318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23307318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23307318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-012-1370-4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23307318

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54276180&oldid=1500915657"